Business Description
EPS Bio Technology Corp
ISIN : TW0004183009
Total Employee Number:
102Description
EPS Bio Technology Corp operates in medical equipment manufacturing, international trade, intellectual property, and research, design, development, manufacture and sale of blood glucose measuring system and cirrhosis testing system. Its products include Test sheet and Glucose machine. Geographically it operates in Germany, Iran, Kingdom of Saudi Arabia, Switzerland, Las Vegas, and Others with majority of the revenue deriving from Germany.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.87 | |||||
Equity-to-Asset | 0.53 | |||||
Debt-to-Equity | 0.5 | |||||
Debt-to-EBITDA | 18.5 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2.11 | |||||
Beneish M-Score | -2.29 | |||||
WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 2.6 | |||||
3-Year EBITDA Growth Rate | -45.4 | |||||
3-Year FCF Growth Rate | -33 | |||||
3-Year Book Growth Rate | -3 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 48.34 | |||||
9-Day RSI | 50.55 | |||||
14-Day RSI | 51.17 | |||||
3-1 Month Momentum % | -14.06 | |||||
6-1 Month Momentum % | -18.15 | |||||
12-1 Month Momentum % | -31.08 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.3 | |||||
Quick Ratio | 1.83 | |||||
Cash Ratio | 0.8 | |||||
Days Inventory | 77.15 | |||||
Days Sales Outstanding | 104.06 | |||||
Days Payable | 80.34 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 4.79 | |||||
3-Year Dividend Growth Rate | -1.4 | |||||
Forward Dividend Yield % | 4.79 | |||||
5-Year Yield-on-Cost % | 4.09 | |||||
Shareholder Yield % | 4.61 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 17.42 | |||||
Operating Margin % | -1.3 | |||||
Net Margin % | -1.57 | |||||
EBITDA Margin % | 1.52 | |||||
FCF Margin % | -4.68 | |||||
OCF Margin % | 0.12 | |||||
ROE % | -2.71 | |||||
ROA % | -1.46 | |||||
ROIC % | -1.79 | |||||
3-Year ROIIC % | -39.57 | |||||
ROC (Joel Greenblatt) % | -2.9 | |||||
ROCE % | -1.99 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shiller PE Ratio | 15.68 | |||||
PS Ratio | 0.67 | |||||
PB Ratio | 1.19 | |||||
Price-to-Tangible-Book | 1.2 | |||||
Price-to-Operating-Cash-Flow | 608.7 | |||||
EV-to-EBIT | -45.13 | |||||
EV-to-EBITDA | 46.11 | |||||
EV-to-Revenue | 0.7 | |||||
EV-to-FCF | -15.02 | |||||
Price-to-GF-Value | 0.61 | |||||
Price-to-Projected-FCF | 0.9 | |||||
Price-to-Median-PS-Value | 0.65 | |||||
| Price-to-Net-Current-Asset-Value | 3.23 | |||||
Earnings Yield (Greenblatt) % | -2.22 | |||||
FCF Yield % | -7.01 | |||||
Forward Rate of Return (Yacktman) % | -1.41 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
EPS Bio Technology Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 499.704 | ||
| EPS (TTM) (NT$) | -0.33 | ||
| Beta | -0.0989 | ||
| 3-Year Sharpe Ratio | -0.59 | ||
| 3-Year Sortino Ratio | -0.92 | ||
| Volatility % | 15.28 | ||
| 14-Day RSI | 51.17 | ||
| 14-Day ATR (NT$) | 0.364835 | ||
| 20-Day SMA (NT$) | 13.9475 | ||
| 12-1 Month Momentum % | -31.08 | ||
| 52-Week Range (NT$) | 11.6 - 20.9 | ||
| Shares Outstanding (Mil) | 23.8 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
EPS Bio Technology Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
EPS Bio Technology Corp Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| TWD 0.670000 Cash Dividend | 2025-08-28 | 19.60 (+0.00%) | ||
| 1.04:1 Stock Split | 2014-10-08 | 14.13 (+0.00%) |
Show
Entries
EPS Bio Technology Corp Frequently Asked Questions
What is EPS Bio Technology Corp(ROCO:4183)'s stock price today?
The current price of ROCO:4183 is NT$14.00. The 52 week high of ROCO:4183 is NT$20.90 and 52 week low is NT$11.60.
When is next earnings date of EPS Bio Technology Corp(ROCO:4183)?
The next earnings date of EPS Bio Technology Corp(ROCO:4183) is .
Does EPS Bio Technology Corp(ROCO:4183) pay dividends? If so, how much?
The Dividend Yield %  of EPS Bio Technology Corp(ROCO:4183) is 4.79% (As of Today), Highest Dividend Payout Ratio of EPS Bio Technology Corp(ROCO:4183) was 6.67. The lowest was 0.29. And the median was 0.94. The  Forward Dividend Yield % of EPS Bio Technology Corp(ROCO:4183) is 4.79%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on EPS Bio Technology Corp
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers